96 related articles for article (PubMed ID: 8525988)
1. Interaction of a sulfhydryl analogue of vasoactive intestinal peptide (VIP) with murine lymphocytes.
Ottaway CA
Adv Exp Med Biol; 1995; 371A():553-8. PubMed ID: 8525988
[No Abstract] [Full Text] [Related]
2. Role of sulfhydryl groups in the binding of vasoactive intestinal peptide to its receptor on murine lymphocytes.
Ottaway CA
J Neuroimmunol; 1992 Jul; 39(1-2):49-56. PubMed ID: 1320058
[TBL] [Abstract][Full Text] [Related]
3. Synergistic action of melatonin and vasoactive intestinal peptide in stimulating cyclic AMP production in human lymphocytes.
Lopez-Gonzalez MA; Calvo JR; Osuna C; Rubio A; Guerrero JM
J Pineal Res; 1992 May; 12(4):174-80. PubMed ID: 1383489
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal peptide downregulates the expression of IL-2 but not of IFN gamma from stimulated murine T lymphocytes.
Ganea D; Sun L
J Neuroimmunol; 1993 Sep; 47(2):147-58. PubMed ID: 8103776
[TBL] [Abstract][Full Text] [Related]
5. Modulatory effects of vasoactive intestinal peptide on immune functions of spleen and lymphoid cells.
Nock IH; Sharma JD
Int J Neurosci; 1990 Apr; 51(3-4):205-6. PubMed ID: 2279867
[No Abstract] [Full Text] [Related]
6. Dual effect of vasoactive intestinal peptide on the mitogenic response of rabbit spleen lymphocytes.
Peuriere S; Susini C; Esteve JP; Vaysse N; Escoula L
Regul Pept; 1990 Jan; 27(1):117-26. PubMed ID: 2155441
[TBL] [Abstract][Full Text] [Related]
7. Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses.
Ottaway CA; Greenberg GR
J Immunol; 1984 Jan; 132(1):417-23. PubMed ID: 6606671
[TBL] [Abstract][Full Text] [Related]
8. A VIP antagonist distinguishes VIP receptors on spinal cord cells and lymphocytes.
Gozes Y; Brenneman DE; Fridkin M; Asofsky R; Gozes I
Brain Res; 1991 Feb; 540(1-2):319-21. PubMed ID: 1647246
[TBL] [Abstract][Full Text] [Related]
9. In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells.
Ottaway CA
J Exp Med; 1984 Oct; 160(4):1054-69. PubMed ID: 6090573
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of mouse T-cell proliferation by CGRP and VIP: effects of these neuropeptides on IL-2 production and cAMP synthesis.
Boudard F; Bastide M
J Neurosci Res; 1991 May; 29(1):29-41. PubMed ID: 1653367
[TBL] [Abstract][Full Text] [Related]
11. Effects of prepro-vasoactive intestinal peptide-derived peptides on the murine immune response.
Yiangou Y; Serrano R; Bloom SR; Peña J; Festenstein H
J Neuroimmunol; 1990; 29(1-3):65-72. PubMed ID: 2170441
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen.
Stanisz AM; Befus D; Bienenstock J
J Immunol; 1986 Jan; 136(1):152-6. PubMed ID: 2415614
[TBL] [Abstract][Full Text] [Related]
13. Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells.
Ottaway CA
Immunology; 1987 Oct; 62(2):291-7. PubMed ID: 2960611
[TBL] [Abstract][Full Text] [Related]
14. Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors.
Gozes I; Lilling G; Glazer R; Ticher A; Ashkenazi IE; Davidson A; Rubinraut S; Fridkin M; Brenneman DE
J Pharmacol Exp Ther; 1995 Apr; 273(1):161-7. PubMed ID: 7714762
[TBL] [Abstract][Full Text] [Related]
15. Limited accumulation of cyclic AMP underlies a modest vasoactive-intestinal-peptide-mediated increase in cytosolic [Ca2+] transients in GH3 pituitary cells.
Mollard P; Zhang Y; Rodman D; Cooper DM
Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):637-40. PubMed ID: 1377907
[TBL] [Abstract][Full Text] [Related]
16. Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC(2) receptors in human and rat and comparison to the pharmacophore for VPAC(1) receptors.
Igarashi H; Ito T; Pradhan TK; Mantey SA; Hou W; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2002 Nov; 303(2):445-60. PubMed ID: 12388623
[TBL] [Abstract][Full Text] [Related]
17. In vivo effect of chronic administration of vasoactive intestinal peptide on gut-associated lymphoid tissues in rats.
Ohkubo N; Miura S; Serizawa H; Yan HJ; Kimura H; Imaeda H; Tashiro H; Tsuchiya M
Regul Pept; 1994 Feb; 50(2):127-35. PubMed ID: 8190914
[TBL] [Abstract][Full Text] [Related]
18. The C-terminal part of VIP is important for receptor binding and activation, as evidenced by chimeric constructs of VIP/secretin.
Wulff B; Møller Knudsen S; Adelhorst K; Fahrenkrug J
FEBS Lett; 1997 Aug; 413(3):405-8. PubMed ID: 9303545
[TBL] [Abstract][Full Text] [Related]
19. Effects of vasoactive intestinal polypeptide (VIP) and cyclic-AMP on the isolated sphincter pupillae muscles of the albino rabbit.
Hayashi K; Masuda K
Jpn J Ophthalmol; 1982; 26(4):437-42. PubMed ID: 6187959
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
Delgado M; Jonakait GM; Ganea D
Glia; 2002 Aug; 39(2):148-61. PubMed ID: 12112366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
